Litiasis urinaria del niño

Van Batavia, 2016, Clinical effectiveness in the diagnosis and acute management of pediatric nephrolithiasis, Int J Surg, 36, 698, 10.1016/j.ijsu.2016.11.030 Tasian, 2016, Annual incidence of nephrolithiasis among children and adults in South Carolina from 1997 to 2012, Clin J Am Soc Nephrol, 11, 488, 10.2215/CJN.07610715 Brener, 2011, Nephrolithiasis: evaluation and management, South Med J, 104, 133, 10.1097/SMJ.0b013e318206f6bd Daudon, 2008, Epidemiology of urolithiasis, Prog Urol, 18, 802, 10.1016/j.purol.2008.09.029 Daudon, 2004, Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach, Urol Res, 32, 241, 10.1007/s00240-004-0421-y Kirejczyk, 2014, An association between kidney stone composition and urinary metabolic disturbances in children, J Pediatr Urol, 10, 130, 10.1016/j.jpurol.2013.07.010 Novak, 2009, Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation, Urology, 74, 104, 10.1016/j.urology.2008.12.079 Alpay, 2009, Clinical and metabolic features of urolithiasis and microlithiasis in children, Pediatr Nephrol, 24, 2203, 10.1007/s00467-009-1231-9 Daudon, 2012 Daudon, 2015, Randall's plaque as the origin of calcium oxalate kidney stones, Urolithiasis, 43, 5, 10.1007/s00240-014-0703-y Ratkalkar, 2011, Mechanisms of stone formation, Clin Rev Bone Miner Metabol, 9, 187, 10.1007/s12018-011-9104-8 Kourambas, 2001, Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis, J Endourol, 15, 181, 10.1089/089277901750134548 Daudon, 2018, Recurrence rates of urinary calculi according to stone composition and morphology, Urolithiasis, 46, 459, 10.1007/s00240-018-1043-0 Daudon, 2004, Composition of renal stones currently observed in non industrialized countries, Prog Urol, 14, 1151 Daudon, 1993, Urinary calculi: review of classification methods and correlations with etiology, Scanning Microsc, 7, 1081 Skolarikos, 2015, Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines, Eur Urol, 67, 750, 10.1016/j.eururo.2014.10.029 Türk, 2016, EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis, Eur Urol, 69, 468, 10.1016/j.eururo.2015.07.040 Mandel, 2003, Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes, J Urol, 169, 2026, 10.1097/01.ju.0000065592.55499.4e Frochot, 2016, Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi, Int J Surg, 36, 624, 10.1016/j.ijsu.2016.11.023 Daudon, 2006, Type 2 diabetes increases the risk for uric acid stones, J Am Soc Nephrol, 17, 2026, 10.1681/ASN.2006030262 Daudon, 2016, Crystalluria analysis improves significantly etiologic diagnosis and therapeutic monitoring of nephrolithiasis, C R Chimie, 19, 1514, 10.1016/j.crci.2016.04.010 Daudon, 2015, Crystalluria, Clin Chem Lab Med, 53, S1479 Daudon, 2003, Cystine crystal volume determination: a useful tool in the management of cystinuric patients, Urol Res, 31, 207, 10.1007/s00240-003-0319-0 Traxer, 2008, Urolithiasis in childhood, Prog Urol, 18, 1005, 10.1016/j.purol.2008.09.037 Becker, 2000, Hyperuricemia and gout Hesse, 2001 Pak, 1975, A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias, N Engl J Med, 292, 497, 10.1056/NEJM197503062921002 Pak, 1974, The Hypercalciurias PAk, J Clin Invest, 54, 387, 10.1172/JCI107774 Cachat, 1993, Renal tubular acidosis in children, Pediatrie, 48, 313 Kovesdy, 2017, World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic, Iran J Kidney Dis, 11, 99 Nikolis, 2017, Blood pressure and urolithiasis in children, J Pediatr Urol, 13, 10.1016/j.jpurol.2016.07.017 Taylor, 2008, Fructose consumption and the risk of kidney stones, Kidney Int, 73, 207, 10.1038/sj.ki.5002588 Stokes, 2017, Hypercalcemic disorders in children, J Bone Miner Res, 32, 2157, 10.1002/jbmr.3296 Alon, 2010, Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia, Pediatr Nephrol, 25, 1747, 10.1007/s00467-010-1547-5 Schlingmann, 2011, Mutations in CYP24A1 and idiopathic infantile hypercalcemia, N Engl J Med, 365, 410, 10.1056/NEJMoa1103864 Molin, 2015, CYP24A1 mutations in a cohort of hypercalcemic patients: evidence for a recessive trait, J Clin Endocrinol Metab, 100, E1343, 10.1210/jc.2014-4387 Prié, 2009, Latest findings in phosphate homeostasis, Kidney Int, 75, 882, 10.1038/ki.2008.643 Schlingmann, 2016, Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia, J Am Soc Nephrol, 27, 604, 10.1681/ASN.2014101025 Iwaki, 2008, A missense mutation in the sodium phosphate co-transporter Slc34a1 impairs phosphate homeostasis, J Am Soc Nephrol, 19, 1753, 10.1681/ASN.2007121360 Dasgupta, 2014, Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis, J Am Soc Nephrol, 25, 2366, 10.1681/ASN.2013101085 Karim, 2008, NHERF1 mutations and responsiveness of renal parathyroid hormone, N Engl J Med, 359, 1128, 10.1056/NEJMoa0802836 Segawa, 2009, Type IIc sodium-dependent phosphate transporter regulates calcium metabolism, J Am Soc Nephrol, 20, 104, 10.1681/ASN.2008020177 Bertholet-Thomas, 2019, Fluconazole as a new therapeutic tool to manage patients with NPTIIc (SLC34A3) mutation: a case report, Am J Kidney Dis, 73, 886, 10.1053/j.ajkd.2018.12.026 Carpenter, 2017, CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations, J Steroid Biochem Mol Biol, 173, 337, 10.1016/j.jsbmb.2017.01.006 Ferraro, 2017, A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass, Urolithiasis, 45, 291, 10.1007/s00240-016-0923-4 Stechman, 2009, Genetic causes of hypercalciuric nephrolithiasis, Pediatr Nephrol, 24, 2321, 10.1007/s00467-008-0807-0 Pedersen, 2018, Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark, J Am Acad Dermatol, 78, 673, 10.1016/j.jaad.2017.11.042 Sayers, 2015, Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole, Clin Kidney J, 8, 453, 10.1093/ckj/sfv028 Claramunt-Taberner, 2018, Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?, Pediatr Nephrol, 33, 1263, 10.1007/s00467-018-3945-z Bouzidi, 2007, Cystinuria: from diagnosis to follow-up, Ann Biol Clin, 65, 473 Gaildrat, 2017, Clinical and molecular characterization of cystinuria in a French cohort: relevance of assessing large-scale rearrangements and splicing variants, Mol Genet Genomic Med, 5, 373, 10.1002/mgg3.294 Elkoushy, 2012, Characterization of patients with heterozygous cystinuria, Urology, 80, 795, 10.1016/j.urology.2012.04.062 Prot-Bertoye, 2019, Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France, BJU Int, 124, 849, 10.1111/bju.14721 Tostivint, 2017, Spectrum of mutations in cystinuria patients presenting with prenatal hyperechoic colon, Clin Genet, 92, 632, 10.1111/cge.13079 Régal, 2018, PREPL deficiency: delineation of the phenotype and development of a functional blood assay, Genet Med, 20, 109, 10.1038/gim.2017.74 Prot-Bertoye, 2015, CKD and its risk factors among patients with cystinuria, Clin J Am Soc Nephrol, 10, 842, 10.2215/CJN.06680714 Joly, 1999, Treatment of cystinuria, Pediatr Nephrol, 13, 945, 10.1007/s004670050736 Alexander, 2019, Renal tubular acidosis, Pediatr Clin North Am, 66, 135, 10.1016/j.pcl.2018.08.011 Seidowsky, 2014, Les acidoses tubulaires rénales, Rev Med Interne, 35, 45, 10.1016/j.revmed.2013.08.012 Blanchard, 2009, Exploration des fonctions tubulaires rénales, Nephrol Ther, 5, 68, 10.1016/j.nephro.2008.03.004 Lopez-Garcia, 2019, Treatment and long-term outcome in primary distal renal tubular acidosis, Nephrol Dial Transplant, 34, 981, 10.1093/ndt/gfy409 Palazzo, 2017, The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis, Kidney Int, 91, 1243, 10.1016/j.kint.2016.12.017 Alonso-Varela, 2018, Distal renal tubular acidosis. Clinical manifestations in patients with different underlying gene mutations, Pediatr Nephrol, 33, 1523, 10.1007/s00467-018-3965-8 Enerbäck, 2018, Acidosis and deafness in patients with recessive mutations in FOXI1, J Am Soc Nephrol, 29, 1041, 10.1681/ASN.2017080840 Santos, 2015, Clinical and laboratory approaches in the diagnosis of renal tubular acidosis, Pediatr Nephrol, 30, 2099, 10.1007/s00467-015-3083-9 de Parscau, 2010, Renalacidosis, Arch Pediatr, 17, 673, 10.1016/S0929-693X(10)70054-3 Cochat, 2013, Primary hyperoxaluria, N Engl J Med, 369, 649, 10.1056/NEJMra1301564 Cochat, 2012, Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment, Nephrol Dial Transplant, 27, 1729, 10.1093/ndt/gfs078 Cochat, 2011, Primary hyperoxaluria, Nephrol Ther, 7, 249, 10.1016/j.nephro.2011.03.004 Harambat, 2012, Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy, Clin J Am Soc Nephrol, 7, 458, 10.2215/CJN.07430711 Fargue, 2018, Hydroxyproline metabolism and oxalate synthesis in primary hyperoxaluria, J Am Soc Nephrol, 29, 1615, 10.1681/ASN.2017040390 Martin-Higueras, 2017, Molecular therapy of primary hyperoxaluria, J Inherit Metab Dis, 40, 481, 10.1007/s10545-017-0045-3 Kukreja, 2019, Systemic alanine glyoxylate aminotransferase messenger RNA improves glyoxylate metabolism in a mouse model of primary hyperoxaluria type 1, Nucleic Acid Ther, 29, 104, 10.1089/nat.2018.0740 Robijn, 2011, Hyperoxaluria: a gut-kidney axis?, Kidney Int, 80, 1146, 10.1038/ki.2011.287 Siener, 2013, Determinants of urolithiasis in patients with intestinal fat malabsorption, Urology, 81, 17, 10.1016/j.urology.2012.07.107 Hoppe, 2005, Hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis, Am J Kidney Dis, 46, 440, 10.1053/j.ajkd.2005.06.003 La Manna, 2001, Hyperuricosuria in children: clinical presentation and natural history, Pediatrics, 107, 86, 10.1542/peds.107.1.86 Dinour, 2010, Homozygous SLC2A9 mutations cause severe renal hypouricemia, J Am Soc Nephrol, 21, 64, 10.1681/ASN.2009040406 Torres, 2007, Hypoxanthine-guanine phosophoribosyl transferase (HPRT) deficiency: Lesch-Nyhan syndrome, Orphanet J Rare Dis, 2, 48, 10.1186/1750-1172-2-48 Bell, 2016, Lesch-Nyhan syndrome: models, theories, and therapies, Mol Syndromol, 7, 302, 10.1159/000449296 Campolo González, 2018, Oral self-mutilation in Lesch-Nyhan Syndrome. Case Report, Rev Chil Pediatr, 89, 86, 10.4067/S0370-41062018000100086 de Brouwer, 2008, Phosphoribosyl pyrophosphate synthetase superactivity, Gene Reviews Becker, 1988, Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness, Am J Med, 85, 383, 10.1016/0002-9343(88)90591-8 Bollée, 2012, Adenine phosphoribosyltransferase deficiency, Clin J Am Soc Nephrol, 7, 1521, 10.2215/CJN.02320312 Ichida, 2001, Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II, Biochem Biophys Res Commun, 282, 1194, 10.1006/bbrc.2001.4719 Carpenter, 1986, Hereditary xanthinuria presenting in infancy with nephrolithiasis, J Pediatr, 109, 307, 10.1016/S0022-3476(86)80391-2 Diss, 2015, Type 1 xanthinuria: Report on three cases, Arch Pediatr, 22, 1288, 10.1016/j.arcped.2015.09.003 Johnson, 2000, Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency Yamamoto, 2002, A pediatric case of ammonium acid urate lithiasis with ulcerative colitis, Nihon Hinyokika Gakkai Zasshi, 93, 652 Bianchi, 2018, Renal lithiasis and inflammatory bowel diseases, an update on pediatric population, Acta Biomed, 89, 76 Abate, 2004, The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance, Kidney Int, 65, 386, 10.1111/j.1523-1755.2004.00386.x Fox, 1972, Studies on the mechanism of fructose-induced hyperuricemia in man, Metabolism, 21, 713, 10.1016/0026-0495(72)90120-5 Stirpe, 1970, Fructose-induced hyperuricaemia, Lancet, 2, 1310, 10.1016/S0140-6736(70)92269-5 Hesse, 2009 Gündüz, 2017, Stents increase the effectiveness of extracorporeal shock wave lithotripsy for pediatric renal stones?, Urol Int, 98, 425, 10.1159/000452451 Gschwend, 1996, Impact of extracorporeal shock wave lithotripsy in pediatric patients: complications and long-term follow-up, Urol Int, 56, 241, 10.1159/000282851 Farhat, 2007, Surgical treatment of pediatric urinary stones, AUA Update Series, 26, 22 Badawy, 2012, Extracorporeal shock wave lithotripsy as first line treatment for urinary tract stones in children: outcome of 500 cases, Int Urol Nephrol, 44, 661, 10.1007/s11255-012-0133-0 Dogan, 2015, A new nomogram for prediction of outcome of pediatric shock-wave lithotripsy, J Pediatr Urol, 11, 84, 10.1016/j.jpurol.2015.01.004 Rodrigues Netto, 2002, Extracorporeal shock wave lithotripsy in children, J Urol, 147, 2164, 10.1016/S0022-5347(05)65119-1 Zeng, 2012, Treatment of renal stones in infants: comparing extracorporeal shock wave lithotripsy and mini-percutaneous nephrolithotomy, Urol Res, 40, 599, 10.1007/s00240-012-0478-y Sen, 2015, Treatment alternatives for urinary system stone disease in preschool aged children: results of 616 cases, J Pediatr Urol, 11, 34, 10.1016/j.jpurol.2014.11.010 Traxer, 1999, Extracorporeal lithotripsy in children: Study of its efficacy and evaluation of renal parenchymal damage by DMSA-Tc 99m scintigraphy: A series of 39 children, Arch Pediatr, 6, 251, 10.1016/S0929-693X(99)80260-7 Vlajkovic, 2002, Long-term functional outcome of kidneys in children with urolithiasis after ESWL treatment, Eur J Pediatr Surg, 12, 118, 10.1055/s-2002-30167 Reisiger, 2007, Pediatric nephrolithiasis: Does treatment affect renal growth?, J Urol, 69, 1190, 10.1016/j.urology.2007.01.072 Elbosky, 2000, Extracorporeal shock wave lithotripsy in children: experience using two second-generation lithotripters, BJU Int, 86, 851, 10.1046/j.1464-410x.2000.00899.x Ritchey, 1988, A case of pediatric ureteroscopic lithotripsy, J Urol, 139, 1272, 10.1016/S0022-5347(17)42890-4 Silay, 2017, Update on urinary stones in children: Current and future concepts in surgical treatment and shockwave lithotripsy, Eur Urol Focus, 3, 164, 10.1016/j.euf.2017.07.005 Ishii, 2015, Ureteroscopy for stone disease in the pediatric population: a systematic review, BJU Int, 115, 867, 10.1111/bju.12927 Smaldone, 2009, The evolution of the endourologic management of pediatric stone disease, Indian J Urol, 25, 302, 10.4103/0970-1591.56177 Salerno, 2013, Treatment of pediatric renal stones in western country: a changing pattern, J Pediatr Surg, 48, 835, 10.1016/j.jpedsurg.2012.09.058 BayrakO, 2012, Comparative analyses of percutaneous nephrolithotomy versus open surgery in pediatric urinary stone disease, Pediatr Surg Int, 28, 1025, 10.1007/s00383-012-3130-6